1. Home
  2. SIGA

SIGA

SIGA Technologies Inc.

Logo SIGA Technologies Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Founded: 1995 Country:
United States
United States
Employees: 45 City: NEW YORK
Market Cap: 626.3M IPO Year: 1997
Target Price: N/A AVG Volume (30 days): 753.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.95 EPS Growth: 106.52
52 Week Low/High: $4.22 - $10.00 Next Earning Date: 05-02-2024
Revenue: $139,917,220 Revenue Growth: 26.31%
Revenue Growth (this year): 38.95% Revenue Growth (next year): -11.16%

Share on Social Networks: